Ara
Toplam kayıt 59, listelenen: 11-20
GEMIFLOXACIN-INDUCED ALLERGIC MYOCARDIAL INFARCTION: A CASE REPORT
(Elsevier Science Inc, 2019)
Background: Gemifloxacin given once daily for 5-7 days has been shown to be non-inferior to, or in some instances superior to, comparator agents for the treatment of common lower respiratory tract infections. Gemifloxacin ...
Thrombolysis in pulmonary embolism: full-dose, low-dose, or catheter-directed thrombolysis?
(W B Saunders Co-Elsevier Inc, 2016)
Letter to the Editor
Takotsubo (stress) cardiomyopathy in childhood
(Springer, 2020)
Takotsubo cardiomyopathy (TC) is a significant cause of acute heart failure in adults. However, triggering factors, ECG and echocardiographic findings, and prognosis of TC have not been well studied in children. Therefore, ...
Ivabradine in cardiogenic shock: Fact or fiction?
(Mosby-Elsevier, 2015)
Letter to the Editor
Metoprolol vs ivabradine in patients with mitral stenosis
(Elsevier Ireland Ltd, 2016)
[No abstract available]
Risk stratification in intermediate-risk acute pulmonary embolism
(W B Saunders Co-Elsevier Inc, 2016)
Obesity and atrial fibrillation
(Elsevier Ireland Ltd, 2016)
Letter to Editor
Thrombolytic Therapy in Pulmonary Embolism: Treating the Patient, Not Just the Disease
(Elsevier Science Inc, 2017)